Improving consistency of cell-based assays by using division-arrested cells

被引:13
作者
Fursov, N
Cong, M
Federici, M
Platchek, M
Haytko, P
Tacke, R
Livelli, T
Zhong, Z
机构
[1] Cell & Mol Technol Inc, Phillipsburg, NJ 08865 USA
[2] Cell & Mol Technol Inc, N Wales, PA USA
关键词
D O I
10.1089/adt.2005.3.7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In this article we describe the use of division-arrested cells for cell-based assays designed for high-throughput screening. Cells are the most critical and variable reagent for cell-based high-throughput screening. The robustness of robotic screening depends on the quality and consistency of cell reagents. We demonstrate that for most cell types commonly used for high-throughput screening, cells can be irreversibly division-arrested by mitomycin C treatment at doses that cause no apparent toxicity or obvious change to the cell signaling properties we measured. Our data also suggest that division-arrested cells perform favorably compared to regular growing cells in reporter and calcium flux assays, two platforms most commonly used in robotic screening. Division arrest technology effectively uncouples the process of cell production from robotic screening and brings the convenience of having quality-approved cell reagent on demand for cell-based high-throughput screening.
引用
收藏
页码:7 / 15
页数:9
相关论文
共 18 条
[1]   Differential activation of p53 by the various adducts of mitomycin C [J].
Abbas, T ;
Olivier, M ;
Lopez, J ;
Houser, S ;
Xiao, G ;
Kumar, GS ;
Tomasz, M ;
Bargonetti, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) :40513-40519
[2]  
BIZANEK R, 1993, CANCER RES, V53, P5127
[3]  
CHANDRASEKARAN V, 2004, 10 SOC BIOM SCREEN A
[4]  
FEDERICI M, 2003, 9 SOC BIOM SCREEN AN
[5]  
FURSOV N, 2004, IBCS DRUG DISC TECHN
[6]   Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells [J].
Goodwin, BL ;
Solomonson, LP ;
Eichler, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (18) :18353-18360
[7]  
GROVE GN, 2004, LABAUTOMATION 2004 C
[8]   Cellular platforms for HTS: three case studies [J].
Johnston, PA ;
Johnston, PA .
DRUG DISCOVERY TODAY, 2002, 7 (06) :353-363
[9]   ECTOPIC EXPRESSION OF THE SEROTONIN 1C RECEPTOR AND THE TRIGGERING OF MALIGNANT TRANSFORMATION [J].
JULIUS, D ;
LIVELLI, TJ ;
JESSELL, TM ;
AXEL, R .
SCIENCE, 1989, 244 (4908) :1057-1062
[10]   A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding [J].
Lin, PF ;
Blair, W ;
Wang, T ;
Spicer, T ;
Guo, Q ;
Zhou, NN ;
Gong, YF ;
Wang, HGH ;
Rose, R ;
Yamanaka, G ;
Robinson, B ;
Li, CB ;
Fridell, R ;
Deminie, C ;
Demers, G ;
Yang, Z ;
Zadjura, L ;
Meanwell, N ;
Colonno, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) :11013-11018